T. de Vries

发表

Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.

M. Mack, P. Serruys, F. Mohr, 2013, International journal of cardiology.

Generalized pairwise comparison methods to analyze (non)prioritized composite endpoints

G. Molenberghs, M. Leon, J. Verbeeck, 2019, Statistics in medicine.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, P. Jüni, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II).

A. Jeremias, P. Serruys, P. Kaul, 2015, JACC. Cardiovascular interventions.

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study

P. Serruys, A. Íñiguez, D. Dudek, 2021, European heart journal.

Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document.

P. Serruys, G. Stone, H. Garcia-Garcia, 2018, JACC. Cardiovascular interventions.

Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and ClinicalOutcomes in Patients With AcuteCoronary Syndrome

H. White, S. Windecker, M. Valgimigli, 2022 .

The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.

Michail I. Papafaklis, M. Mack, P. Serruys, 2013, Journal of the American College of Cardiology.

Two years clinical outcomes with the state‐of‐the‐art PCI for the treatment of bifurcation lesions: A sub‐analysis of the SYNTAX II study

P. Serruys, J. Escaned, P. Chichareon, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

P. Serruys, A. Íñiguez, D. Dudek, 2017, European heart journal.

Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score

M. Mack, P. Serruys, F. Mohr, 2013, Circulation.

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention.

P. Serruys, S. Silber, P. Jüni, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Response to letter regarding article, "Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial: validation of the residual SYNTAX Score".

P. Serruys, F. Mohr, T. Feldman, 2014, Circulation.

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials

Jeroen J. Bax, M. Leon, P. Pibarot, 2019, Cardiac failure review.

Diagnostic Accuracy of Baseline Distal-to-Aortic Pressure Ratio to Assess Coronary Stenosis Severity: A Post-Hoc Analysis of the ADVISE II Study.

P. Serruys, H. Garcia-Garcia, J. Piek, 2015, JACC. Cardiovascular interventions.

The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).

Dick M. Goedhart, F. Eberli, P. Serruys, 2010, The American journal of cardiology.

Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: An analysis of the SYNTAX Study

M. Mack, P. Serruys, F. Mohr, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

First generation versus second generation drug‐eluting stents for the treatment of bifurcations: 5‐year follow‐up of the LEADERS all‐comers randomized trial

F. Eberli, P. Serruys, R. D. de Winter, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.

P. Serruys, J. Wykrzykowska, S. Windecker, 2016, Cardiology journal.

Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.

F. Eberli, P. Serruys, J. Wykrzykowska, 2009, JACC. Cardiovascular interventions.

Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.

P. Serruys, J. Tijssen, Y. Onuma, 2017, JACC. Cardiovascular interventions.

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial.

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.

E. Steyerberg, M. Mack, P. Serruys, 2012, European heart journal.

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.

E. Steyerberg, P. Serruys, L. Räber, 2012, European heart journal.

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomi

F. Eberli, P. Serruys, S. Windecker, 2022 .

Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial

Dick M. Goedhart, F. Eberli, P. Serruys, 2011, Circulation. Cardiovascular interventions.

Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial.

F. Eberli, P. Serruys, J. Wykrzykowska, 2010, Journal of the American College of Cardiology.

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

P. Serruys, S. Silber, J. Wykrzykowska, 2013, Heart.

The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer.

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document.

Jonathan H Seltzer, C. Held, P. Serruys, 2019, JACC. Cardiovascular interventions.

Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial.

M. Mack, P. Serruys, F. Mohr, 2013, Journal of the American College of Cardiology.

Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study

Antonis Sakellarios, Dimitrios I. Fotiadis, Pieter H. Kitslaar, 2017, European heart journal cardiovascular Imaging.

A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2010, JACC. Cardiovascular interventions.

Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trial.

E. Steyerberg, P. Serruys, G. Stone, 2014, Journal of the American College of Cardiology.

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.

P. Fitzgerald, P. Serruys, K. Stangl, 2010 .

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, S. Garg, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials.

P. Serruys, L. Räber, S. Garg, 2011, JACC. Cardiovascular interventions.

Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.

F. Eberli, P. Serruys, L. Räber, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Noninvasive Prediction of Atherosclerotic Progression: The PROSPECT-MSCT Study.

Antonis Sakellarios, Dimitrios I Fotiadis, Paschalis Bizopoulos, 2016, JACC. Cardiovascular imaging.

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial.

P. Fitzgerald, P. Serruys, J. Iqbal, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

P. Serruys, S. Silber, J. Wykrzykowska, 2013, Heart.

Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial.

H. White, S. Windecker, M. Valgimigli, 2016, JACC. Cardiovascular interventions.

A. Jeremias, P. Serruys, P. Kaul, 2015, JACC. Cardiovascular interventions.